Table 1.
Demographic and clinical characteristics of the patients.
| Patient’s characteristics | Seizure (n = 10) | No seizure (n = 10) |
|---|---|---|
| Age—years (mean) | 46.0 | 45.0 |
| Female sex—no. (%) | 3 (30.0) | 7 (70.0) |
| Number of performed surgery | ||
| 1 | 6 | 4 |
| 2 | 2 | 5 |
| 3 | 2 | 1 |
| Tumour grading | ||
| Grade I | 4 | 4 |
| Grade II | 4 | 5 |
| Grade III | 2 | 1 |
| IDH-1 (-/+) | 2/8 | 1/9 |
| Location of tumour | ||
| Extratemporal | 8 | 8 |
| Temporal | 2 | 2 |
| Side of tumour | ||
| Right | 5 | 6 |
| Left | 4 | 2 |
| Bilateral | 1 | 1 |
| Seizure semiology | ||
| Focal onset with impaired awareness | 2 | 0 |
| Generalized seizure | 6 | 0 |
| Unknown onset | 2 | 0 |
| Seizure frequency | ||
| No in the past 3 month | 3 | 0 |
| 1 or more but less than 1 per month | 3 | 0 |
| More than 1 per month but no more than 1 per week | 3 | 0 |
| More than 1 per week but not more than 1 per day every day | 1 | 0 |
| Adjuvant treatment | ||
| Radiotherapy | 9 | 8 |
| Chemotherapy | 3 | 3 |
| Other neurological symptoms | ||
| Headache | 5 | 7 |
| Weakness | 4 | 4 |
| Numbness | 0 | 2 |
| Cognitive impairment | 1 | 3 |
| Ataxia | 0 | 2 |
| Blurred vision | 1 | 1 |
| Asymptomatic | 3 | 0 |
| AEDs before surgery | ||
| Yes | 10 | 0 |
| No | 0 | 5 |
| Present with seizure | ||
| Yes | 9 | 0 |
| No | 1 | 10 |
| Post-surgical seizure | ||
| No | 5 | 10 |
| At least daily | 2 | 0 |
| At least weakly | 0 | 0 |
| At least months | 3 | 0 |
| Tumour volume (cm3) | 138.46 | 127.61 |
| Perilesional oedema | ||
| No | 3 | 0 |
| Mild | 5 | 6 |
| Moderate | 2 | 1 |
| Severe | 0 | 3 |
| Intra-tumoural haemorrhage | ||
| Yes | 1 | 4 |
| No | 9 | 6 |
| Last follow up (months) | 45.5 | 31.8 |
| MRS score | ||
| 0 | 5 | 1 |
| 1 | 1 | 2 |
| 2 | 0 | 3 |
| 3 | 1 | 0 |
| 4 | 2 | 0 |
| 5 | 0 | 4 |
| 6 | 1 | 0 |
| Status at last follow | ||
| Alive | 9 | 10 |
| Dead | 1 | 0 |